Orexigen

Short answer: generally no — compounded GLP‑1s are not the best first option. They carry safety, potency and regulatory risks and aren’t FDA‑approved, so try safer, more reliable routes first. Why compounded GLP‑1s are risky Potency and purity can vary, especially if made from bulk API sourced overseas. Injectables require strict sterile compounding (USP <797>); mistakes risk infection. No FDA approval or standard labeling, and most insurers won’t cover them. The FDA has warned about compounded semaglutide products in the past. Safer alternatives to try first (with brands/services) Appeal the denial / prior authorization Ask your prescriber to file an appeal or do a peer‑to‑peer with your insurer. Include BMI, comorbidities (diabetes, hypertension, sleep apnea), and prior weight‑loss attempts. This often overturns denials. Manufacturer support and copay assistance Novo Nordisk savings card / patient support for Wegovy (check eligibility — often available to commercially insured). Lilly patient support / Zepbound resources (if tirzepatide for weight management is an option). These programs can dramatically lower out‑of‑pocket cost for commercially insured patients. Patient assistance and discount services NeedyMeds, Partnership for Prescription Assistance, PAN Foundation (check eligibility). Prescription discount cards: GoodRx, SingleCare, Blink Health can reduce cash price for some GLP‑1s. Consider other FDA‑approved options Ozempic (semaglutide, Novo Nordisk) — diabetes indication but sometimes covered by insurers and used off‑label for weight. Rybelsus (oral semaglutide) — oral option for diabetes. Zepbound (tirzepatide, Eli Lilly) — approved for weight management; may have different coverage. Mounjaro (tirzepatide for T2D, Lilly) — used for diabetes and sometimes accessible. Saxenda (liraglutide, Novo Nordisk), Qsymia (phentermine/topiramate, Vivus), Contrave (naltrexone/bupropion, Orexigen) — older weight‑loss meds that insurers sometimes cover when Wegovy is denied. Specialty pharmacies and weight‑management clinics Ask your prescriber to work with a specialty pharmacy or an obesity medicine clinic — they often have staff to navigate prior authorizations and manufacturer programs. If you’re still considering a compounded GLP‑1 Only as a last resort, and only from a reputable, accredited sterile compounding pharmacy that: Provides a certificate of analysis for ingredients, batch sterility testing, and explicit compounding source (not bulk, unregulated API), and follows USP standards. Ask your prescriber to weigh the benefits vs safety/quality risks and to document that FDA‑approved therapies were tried or are inaccessible. If you want, I can: Draft appeal language your prescriber can use for a prior authorization or peer‑to‑peer. Look up patient assistance programs that match your insurance type (commercial vs Medicare/Medicaid) or local accredited compounding pharmacies to vet alternatives. Which insurance (commercial, Medicare, Medicaid) and is the prescription for weight loss or diabetes? That will help me give concrete next steps.

Mentioned in position 10 of 10